VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Purchased by CoreFirst Bank & Trust

CoreFirst Bank & Trust grew its holdings in shares of VanEck Pharmaceutical ETF (NASDAQ:PPHFree Report) by 821.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 8,750 shares of the company’s stock after purchasing an additional 7,800 shares during the period. CoreFirst Bank & Trust’s holdings in VanEck Pharmaceutical ETF were worth $712,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Allworth Financial LP acquired a new position in shares of VanEck Pharmaceutical ETF during the fourth quarter valued at $28,000. Cary Street Partners Investment Advisory LLC acquired a new position in shares of VanEck Pharmaceutical ETF during the third quarter valued at $60,000. Almanack Investment Partners LLC. acquired a new position in shares of VanEck Pharmaceutical ETF during the fourth quarter valued at $225,000. Blair William & Co. IL increased its holdings in shares of VanEck Pharmaceutical ETF by 306.8% during the third quarter. Blair William & Co. IL now owns 3,588 shares of the company’s stock valued at $287,000 after purchasing an additional 2,706 shares during the period. Finally, Private Client Services LLC acquired a new position in shares of VanEck Pharmaceutical ETF during the fourth quarter valued at $298,000.

VanEck Pharmaceutical ETF Trading Down 0.1 %

PPH stock traded down $0.06 during trading hours on Monday, hitting $91.62. 150,698 shares of the stock traded hands, compared to its average volume of 140,796. The stock has a 50-day simple moving average of $88.91 and a 200 day simple moving average of $86.89. VanEck Pharmaceutical ETF has a one year low of $74.05 and a one year high of $92.97. The company has a market cap of $544.22 million, a P/E ratio of 21.04 and a beta of 0.72.

VanEck Pharmaceutical ETF Dividend Announcement

The company also recently announced a dividend, which was paid on Friday, April 5th. Investors of record on Tuesday, April 2nd were paid a dividend of $0.5328 per share. The ex-dividend date was Monday, April 1st.

VanEck Pharmaceutical ETF Profile

(Free Report)

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.

See Also

Want to see what other hedge funds are holding PPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for VanEck Pharmaceutical ETF (NASDAQ:PPHFree Report).

Institutional Ownership by Quarter for VanEck Pharmaceutical ETF (NASDAQ:PPH)

Receive News & Ratings for VanEck Pharmaceutical ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Pharmaceutical ETF and related companies with MarketBeat.com's FREE daily email newsletter.